No hiding for black triangle drugs as EMA prepares public list
This article was originally published in SRA
Executive Summary
A list of all EU drugs needing a black inverted triangle on their package leaflets and summary of product characteristics (SmPCs) will soon be published by the European Medicines Agency1. The triangle is mandated by the EU pharmacovigilance legislation and is needed on drugs subjected to additional monitoring2.